LBT INNOVATIONS LIMITED

Medical technology company commercialising the first and only FDA cleared instrument using Artificial Intelligence (AI) which automates reading of culture plates in hospitals and microbiology laboratories globally. This first in class technology has US-FDA, CE Mark and TGA regulatory clearances and is available for sale in the United States, the European Union and Australia. The AI algorithm and intelligent imaging platform technology is patent protected, clinically proven through a 10,000 patient clinic trial with reference customer sites established in the US, EU and AU, with early sales.